| 名稱 | FGFR2(E17)-AHCYL1(E2) Fusion 標(biāo)準(zhǔn)品 |
| 型號(hào) | CBP20183R |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FGFR2(E17)-AHCYL1(E2) Fusion |
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > Fusion > CBP20183RFGFR2(E17)-AHCYL1(E2) Fusion 標(biāo)準(zhǔn)品
- 詳細(xì)內(nèi)容
CBP20183R | |
| Format | RNA |
| Description | FGFR2, fibroblast growth factor receptor 2, is a receptor tyrosine kinase activated upon binding of the FGF ligand, which activates RAS-MAPK and PI3K-AKT pathways (PMID: 22508544). Altered function of FGFR2 through activating mutations, fusions, and amplification increases cell proliferation and tumorigenesis (PMID: 22508544) and is observed in prostate (PMID: 30761180), breast, lung, uterine, and ovarian cancers (PMID: 29104507), while FGFR2 amplification (PMID: 31076567) and overexpression (PMID: 30662521) is commonly observed in gastric cancer. |
| Technical Data | |
| Left Gene | FGFR2 |
| Left Breakpoint | chr10:123243212:- |
| Right Gene | AHCYL1 |
| Right Breakpoint | chr1:110551656:+ |
| Cosmic ID | N/A |
| Buffer | RNase-free H2O |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| RNA electrophoresis | Download for COA |
| Sanger sequencing | Download for COA |
| Storage | -80℃ |
| Expiry | 12 months from the date of manufacture |
員_a.png)